As we age, NAD+ levels naturally decline, which can contribute to various health issues and the aging process itself.NAD+ IV therapy aims to replenish and maintain optimal levels of NAD+ in the body
Post-hoc analyses from clinical trials show tirzepatide may reduce high-sensitivity C-reactive protein (hsCRP) levels, though reductions appear to correlate with weight loss and improved glycemic control
2 The study evaluated the efficacy and safety of once-daily oral semaglutide with lifestyle counseling compared with placebo
Germany is expected to maintain its leadership position with a 26.8% market share in 2025, remaining stable at 26.6% by 2035, supported by its advanced healthcare technology sector, precision diabetes care capabilities, and comprehensive pharmaceutical innovation facilities serving European and international markets
2B, right-hand panel, higher magnification insert)
Funk, C., Gmr, J., Herold, R